What is Microcube?
Microcube operates as a vertically integrated medical device powerhouse, distinguishing itself through a self-sufficient, start-to-finish development model. The firm functions as an innovation hub, concurrently managing multiple high-stakes projects that span the entire product lifecycle—from initial clinical need identification and concept design to rapid prototyping, intellectual property management, and final regulatory submission. By housing diverse clinical expertise and engineering capabilities under one roof, Microcube effectively reduces the friction typically associated with bringing breakthrough medical technologies to market. Their unique organizational culture, which emphasizes mentorship and cross-disciplinary collaboration, serves as a catalyst for their ability to deliver turnkey product procedures that address critical gaps in modern clinical practice.
How much funding has Microcube raised?
Microcube has raised a total of $359K across 2 funding rounds:
Debt
$150K
Debt
$209K
Debt (2020): $150K with participation from PPP
Debt (2021): $209K led by PPP
Key Investors in Microcube
PPP
Public-Private Partnership
What's next for Microcube?
With the recent influx of capital, Microcube is well-positioned to accelerate its pipeline of cutting-edge medical projects. The strategic focus will likely shift toward expanding its clinical trial infrastructure and deepening its market mapping capabilities to ensure that its latest innovations achieve rapid adoption. As the company moves into this next phase of growth, the emphasis will remain on scaling its multi-disciplinary teams and refining its internal IP management systems. By leveraging its current financial momentum, Microcube aims to solidify its role as a primary architect of future clinical standards, potentially exploring new therapeutic areas where its rapid-prototyping methodology can provide a distinct competitive advantage in the global medtech landscape.
See full Microcube company page
